vitaTrackr Showcases Strategic Partner - MedCitti

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
vitaTrackr Showcases Strategic Partner - MedCitti

Baltimore, April 30, 2014 (GLOBE NEWSWIRE) -- vitaTrackr, Inc., the global leader in organizing an independent and agnostic health data market today announces MedCitti as a Spotlight Strategic Partner.

"Since launching the vitaTrackr Strategic Partner Program on April 8, vitaTrackr has heard from companies across all sectors. Some well-established, others early stage - all share a vision of a better, more efficient health system" said Brian Baum, founder and CEO of vitaTrackr. "Data" of itself is of limited value; where things get interesting is when the participants of the vitaTrackr marketplace engage and add value to it. It is there that the future of healthcare lies. Given the diversity of companies joining the Partner Program, vitaTrackr will periodically showcase the businesses of our partners.

MedCitti is an exciting early stage company that has a talented team, incredible research and patent-pending technology. MedCitti's methodology applies evidence based regression analysis to analyze and estimate future lifetime treatment costs and out-of-pocket expenses for diseases related to obesity. Reports can be processed at a population level and down to the individual (age 18 and above). An android based application can be used by individual consumers to understand the impact of their health decisions, the future costs of those decisions and actions they can take to modify outcomes and costs. The app also updates cost projections based on changes in body mass index and risk factors. Consumers can use the information provided to monitor their health, adopt health improvement strategies to improve health and mitigate costs.

Dr. Neela Srinivas, founder and Chief Data Scientist of MedCitti said "our application at the consumer level currently utilizes age and BMI as variables for analysis. With these variables, the accuracy of our application for general forecasts is significantly high. The vitaTrackr marketplace provides the opportunity to obtain additional consumer authorized data such as blood pressure, cholesterol, blood sugar and many other metrics. The accuracy of our application will increase exponentially for personalized forecasts."

Dr. Sri Halthore, Chief Medical Officer of MedCitti , stated that "the objective of MedCitti is to empower people to help themselves improve their health and the quality of their life. Applied data is the foundation."

"vitaTrackr is exciting, but watching organizations join a neutral health data marketplace, innovate new solutions and improve care - that is the future of healthcare", said Baum.

If your company is interested in ushering in the era of data-enabled healthcare, join the vitaTrackr Strategic Partner Program. Download a registration kit at http://www.vitatrackr.com/partner-program.html

About vitaTrackr:

vitaTrackr is a health data marketplace facilitating the movement of health data from point of creation to qualified destinations that value it. The vitaTrackr marketplace is an industry-wide utility benefiting all, but advantaging no individual sector or entity. The consumer, (data owner) authorizes data transfers.

www.vitaTrackr.com

Join the discussion www.healthdataneutrality.com

About MedCitti:

MedCitti bends the cost curve in healthcare with outcomes focused preventive strategies powered by data analytics. Its patent pending methodology leverages historic member data, medical evidence and statistical regression models to estimate future risk factors, treatment costs, out-of-pocket expenses and direct payments by insurance companies. The MedCitti software-as-a-service platform supports organizational health management and extends its application to individuals via an android based application to manage health risks and costs.

www.MedCitti.com

XXX

vitaTrackr, Inc. MedCitti Brian Baum Dr. Neela Srinivas CEO, vitaTrackr, Inc. Founder, Chief Data Scientist 410.489.2841 732.893.0951 www.vitaTrackr.com www.medcitti.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ribo Advances Lipid Disorder Strategy with SR122 Trial

Updated Category News Views 114

Ribo's New Chapter in Lipid Disorders For those keeping tabs on the cutting-edge of lipid research, Ribo’s latest maneuver isn't one to skim over. The company, hailing from both Suzhou and Sweden, just moved forward by submitting its Phase I Clinical Trial Application in Europe for a fascinating compound: SR122. This development isn’t just another filing; it marks a...

Continue Reading
Quest Diagnostics at Jefferies Conference: What’s Next?

Updated Category News Views 65

Quest Diagnostics Set for the Spotlight in London You're sipping your morning coffee when you hear that Quest Diagnostics (NYSE: DGX) is gearing up for a fireside chat in the UK's capital. Now, this isn't a random chit-chat we're talking about. Sam Samad, the man handling the books as their CFO, will be chatting it up at the Jefferies Global Healthcare Conference on...

Continue Reading
Burtch Works Joins Databricks: Fueling AI Success

Updated Category News Views 20

Game-Changer for AI Talent Market First off, let me tell you, in this data-driven world, finding solid AI talent is like hitting the jackpot. Burtch Works teaming up with Databricks? That's like leaping into a goldmine fully prepared. We're talking about forward-deployed engineers and specialized AI talent coming straight to your door. Closing the Impossible Talent Gap...

Continue Reading
Bimbo Bakeries Teamsters Gear Up for Strike in NJ

Updated Category News Views 102

A Brewing Storm at Bimbo Bakeries The morning air in East Brunswick fills with more than just the scent of fresh bread; there’s a tension you can slice through with a butter knife. Unwavering and fired-up, over 90 workers at Bimbo Bakeries have thrown their hats into the ring, ready to strike to protect something as sacred as the dough they churn—Teamsters' health...

Continue Reading
Zura Bio Faces Tough Road After Trial Failure

Updated Category News Views 155

Investor Dilemma: ZURA Takes a Nosedive November 9, 2026, wasn't a day to remember for anyone holding shares in Zura Bio. If ever there's a classic lesson in biotech investing's volatility, this is it: shares of Zura Biotech (NASDAQ:ZURA) cratered by about 72% after news broke that their much-hyped Phase 2 TibuSHIELD trial for tibulizumab hit the skids. For a company that...

Continue Reading
Gold.com Faces Fiduciary Investigation by Levi & Korsinsky

Updated Category News Views 56

Gold.com in Hot Water: What Shareholders Need to Know You ever wonder how firms like Gold.com find themselves in sticky situations before the ink's dry on the quarterly report? Well, strap in because Levi & Korsinsky, LLP is poking around to see if some officers and directors over there have taken a stroll down Breach Avenue. And let me tell you, if you're holding onto...

Continue Reading
Cloud Software Group's $2B Debt Offer Wraps Up

Updated Category News Views 115

Sizing Up Cloud Software Group’s Recent Maneuver Whoever thought navigating debt was a dull spectacle hasn’t kept up with Cloud Software Group's recent financial theatrics. With a $2 billion cap on the table, their cash tender offer for 9.00% Senior Secured Second Lien Notes due 2029 didn’t just happen; it paraded onto the financial stage and left a noteworthy...

Continue Reading
Inner City Visions Celebrates Two Decades of Impact

Updated Category News Views 126

Alfred Lomas' Transformation Fuels Lasting Change Once upon a time, Alfred Lomas was known as a brawler in the rough patches of South L.A., running with gangs and entangled in violence. But the story flipped, and instead of leaning into chaos, Lomas leaned into hope. That personal turnaround isn't just a headline—it's the crux behind Inner City Visions (ICV), the...

Continue Reading
Mesh Security Bolsters Team with Five Cybersecurity Experts

Updated Category News Views 252

New Blood in Cybersecurity: Mesh's Strategic Moves Ever felt like the cybersecurity world is in a constant game of catch-up? You're not wrong. In today's digital battleground, companies don't just need more tools—they need collective wisdom to bind it all together. And it seems like Mesh Security just caught onto that notion, stacking their deck with five new...

Continue Reading
Charitable Giving Turbocharges E-commerce Conversion Rates

Updated Category News Views 50

Charitable Giving: The Secret Sauce for E-commerce Success In an e-commerce arena teeming with bland sameness, charitable giving is proving to be a game-changing hook. That's right—brands partnering with Change and DailyKarma have found a magic formula where customers flourish and causes benefit. With over $7.4 million in donations spread across more than 3 million...

Continue Reading

Top 5 Most Recently Viewed Articles

Get A Drip Names New CMO Amid Longevity Boom

Updated Category News Views 21

So, here's a curveball in the health gig—longevity's caught a second wind. And who's riding the wave? Get A Drip, the UK hotshot in the wellness league. They've just snagged Dr. Luke Pratsides as their new Chief Medical Officer. Imagine adding a sharp arrow to the quiver at a time when folks are head-over-heels for living longer and staying healthier. Longevity at the...

Continue Reading
Class Action Lawsuit Alert for Marex Group Investors - Act Now!

Updated Category News Views 157

Attention Investors: Marex Group Class Action Lawsuit Announced Investors in Marex Group plc (NASDAQ: MRX) should take note of an important development. A class action lawsuit has been initiated against Marex on behalf of those who purchased shares during the specified time frame. This legal action addresses serious allegations of financial misconduct, leading to...

Continue Reading
Navigating Political Challenges: Macron's Strategy with Barnier

Updated Category News Views 69

Understanding Barnier's New Role in French Politics After navigating the intricate Brexit negotiations, Michel Barnier has now stepped into a demanding role as Prime Minister. This position is crucial for tackling the urgent challenges within France's divided political environment. Challenges Awaiting Barnier Emmanuel Macron selected Barnier to steer his government...

Continue Reading
Verona Pharma Receives Shareholder Approval for Merck Deal

Updated Category News Views 211

Verona Pharma's Shareholders Greenlight Merck Acquisition In a significant step for Verona Pharma, shareholders have given the green light for the proposed acquisition by Merck & Co., marking a pivotal moment in the biopharmaceutical company's journey. Verona Pharma plc, listed on Nasdaq under the ticker VRNA, focuses on developing innovative therapies for chronic...

Continue Reading
2024 Luxury Resale Insights from The RealReal

Updated Category News Views 818

Insights from The RealReal's 2024 Luxury Resale Report Consumers Lead the Charge, Redefining Trends and Investing in Lasting Value The RealReal, the largest online marketplace for authenticated resale luxury goods, has unveiled its seventh annual 2024 Luxury Resale Report. This extensive report draws on 13 years of data to analyze the current state of luxury resale,...

Continue Reading